Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
19 March 2019 | Story Thabo Kessah | Photo Thabo Kessah
Thokozile Thulo
Thokozile Thulo says the UFS has changed its focus in supporting students with disabilities.
The Centre for Universal Access and Disability Support (CUADS) has recently opened a permanent office on the Qwaqwa Campus The centre aims to ensure that the University of the Free State increasingly becomes a universally accessible higher-education institution which embraces students with various disabilities.

Thokozile Thulo, CUADS Assistant Officer at Qwaqwa said: “Our focus has changed from ‘special’ accommodation for individuals to the creation of a learning environment that is welcoming and empowering to all students. Integrated learning and education methodologies and processes are being researched and developed to create more awareness among lecturing staff. This incorporates universal design, faculty instruction and curricula.” 

The CUADS office assists students to gain access to study courses, learning materials, various buildings and residences, computer facilities and specialised exams and tests. For visually-impaired students, study material and textbooks in Braille, audio, e-text or enlarged format are provided. 

The office also supports students with various psychosocial and chronic conditions such as epilepsy and panic disorder, as well as learning difficulties such as dyslexia and hyperactivity. “In addition, we support students with special arrangements such as extra time for tests and exams,” said Thokozile.



News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept